Insider Trading Activity AtriCure (NASDAQ:ATRC) – Director Sold 10,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For AtriCure (NASDAQ:ATRC)

Elizabeth D Krell , Director of AtriCure (NASDAQ:ATRC) reportedly Sold 10,000 shares of the company’s stock at an average price of 22.82 for a total transaction amount of $228,200.00 SEC Form

Insider Trading History For AtriCure (NASDAQ:ATRC)

  • On 8/16/2012 Karen P Robards, Director, bought 1,000 with an average share price of $6.98 per share and the total transaction amounting to $6,980.00.
  • On 8/23/2012 Karen P Robards, Director, bought 1,000 with an average share price of $6.70 per share and the total transaction amounting to $6,700.00.
  • On 9/7/2012 Michael D Hooven, Director, bought 1,215 with an average share price of $6.88 per share and the total transaction amounting to $8,359.20.
  • On 9/10/2012 Michael D Hooven, Director, bought 1,215 with an average share price of $7.15 per share and the total transaction amounting to $8,687.25.
  • On 9/11/2012 Michael D Hooven, Director, bought 1,145 with an average share price of $7.18 per share and the total transaction amounting to $8,221.10.
  • On 9/12/2012 Michael D Hooven, Director, bought 1,150 with an average share price of $7.10 per share and the total transaction amounting to $8,165.00.
  • On 9/13/2012 Michael D Hooven, Director, bought 1,110 with an average share price of $7.37 per share and the total transaction amounting to $8,180.70.

    • Analyst Ratings History For AtriCure (NASDAQ:ATRC)

    • On 8/5/2016 UBS Lower Price Target of rating Sell with a price target of $15.00 ➝ $14.00
    • On 8/6/2016 JMP Securities Set Price Target of rating Buy with a price target of $23.00
    • On 3/6/2017 BTIG Research Downgraded rating Buy ➝ Neutral
    • On 3/20/2017 Northland Securities Reiterated Rating Buy with a price target of $24.00
    • On 6/16/2017 Leerink Swann Reiterated Rating Outperform with a price target of $26.00
    • On 12/10/2017 Piper Jaffray Reiterated Rating Buy with a price target of $24.00
    • On 2/27/2018 Canaccord Genuity Boost Price Target of rating Buy ➝ Buy with a price target of $24.00 ➝ $26.00

    Recent Trading Activity for AtriCure (NASDAQ:ATRC)
    Shares of AtriCure closed the previous trading session at with 23.020000457763672 shares trading hands.